Email Us
The Trial Lawyer Magazine Logo
SUBSCRIBE

Johnson & Johnson to Pay $2 Billion for False Marketing
Johnson & Johnson to Pay $2 Billion for False Marketing

CNN; November 4, 2013

Johnson & Johnson will pay $2.2 billion to settle charges that the company marketed drugs for unapproved uses and paid "kickbacks" to doctors and nursing homes.

The penalties announced Monday involve fines and forfeiture to the federal government and several states. The settlement involves the schizophrenia drugs Risperdal and Invega, and the heart failure drug Natrecor, the company and Attorney General Eric Holder said.

Johnson & Johnson and two subsidiaries "lined their pockets at the expense of American taxpayers, patients and the private insurance industry," Holder said.

The penalty amounts to one of the country's largest health care-related settlements, the Justice Department said.

It also results in what one plaintiff's attorney called the largest whistleblower payout in U.S. history. Whistleblowers in three states will collect $167.7 million under the False Claims Act.

To read the complete article, please click here: https://money.cnn.com/2013/11/04/news/companies/johnson-and-johnson-settlement/index.html?hpt=hp_t2

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
The Trial Lawyer Magazine Logo
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram